Aakaar Medical Technologies IPO Share Allocation: Last GMP, How to Check Status Online | Einsmark news

AKAAR MEDICAL TECHNOLOGICAL IPO Award: The award of AKAAR MEDICAL TECHNOLOGICAL’S INITIAL PUBLIC OFFER (IPO) is likely to be completed today, Wednesday, June 25, to decent interest and subscriptions for the share sale. The £ 27 Crore SME scholarship was open to bidding between June 20 and 24. The price tire for the expense was set in the region of £ 68-72 per share. The company will recognize the shares shares on Thursday, June 26 in the Demat accounts of investors who received the award. Refunds for rejected applications will also be processed the same day. Aakaar Medical IPO will be listed on NSE SME on Friday, June 27, 2025. How to check the IPO Award Status Step 1: Go to the IPO registrar website from Bigshare Services. Step 2: Choose Aakaar Medical Technologies IPO in the selection menu. Step 3: To discover the status, select a mode – click Pan, Demat account or application number. Step 4: Enter the required information, such as your application number, PAN or Demat account number. Step 5: Enter the ‘CAPTCHA’ to verify that you are not a robot. Step 6: Click ‘Submit’ to see the award status. Over the IPO, the AKAAR Medical IPO is completely a new problem of 37.50 Lakh shares with no offer for sale component. The minimum lot size for an application was 1,600 shares, and the minimum investment required by retail investors was £ 1.15 Lakh. The IPO concluded with a decent response and received 2.28 times subscription to the three-day bid period. This has attracted bid for 57 Lakh shares at the 24.96 Lakh shares available. The retail investors’ segment was subscribed to 1.93 times, while the non-institutional investor (NII) category had a 1.48 times subscription. The qualified Institutional Buyers (QIBS) section was the strongest question, which is 3.51 times subscribed. The Aakaar Medical IPO increased £ 7.68 from anchor investors, with the anchor bid taking place on June 19, 2025. The remaining funds will be directed at general corporate purposes, which helps the company to strengthen its operations and overall operational growth. Indorient Financial Services Ltd has served as the general manager of the book by the Aakaar Medical Technologies IPO, while Bigshare Services PVT Ltd has acted as the registrar of the issue. Alacrity Securities Ltd has been appointed as the Market Maker for the IPO. About the company founded in June 2013, Aakaar Medical Technologies Limited is an aesthetic healthcare business that offers a wide range of specialized cosmetic products and medical devices. The company mainly provides for dermatologists, plastic surgeons, aesthetic doctors and cosmetics, which offer both domestic manufactured items among its own brands and imported products from countries such as South Korea, Spain, Italy and Austria. The product setup contains a mixture of internal and international brands, focusing on solutions used in clinical treatments, as well as products sold to end consumers. Axis Medical Technologies mainly deliver its offer to medical experts, who use it in aesthetic procedures or sell it directly to clients. Axaar Medical Technologies Limited has reported a constant increase in its profitability over the past three financial years. The company’s profit to tax (PAT) rose from £ 2.15 crore in FY23 to £ 2.87 crore in FY24, and further to £ 6.04 in FY25. Operations revenue also showed a constant growth, which rose from £ 32.78 crore in FY23 to £ 46.11 in FY24, reaching £ 61.58 in FY25. AKAAR MEDICAL IPO GMP Today is the IPO’s Gray Market Premium (GMP) today £ 0 per share. This indicates an expected listing price of £ 72, the same as the issue price. Disclaimer: The views and recommendations above are those of individual analysts or brokerage companies, not coin. We advise investors to check with certified experts before making investment decisions.